Galapagos NV
GLPG
#4537
Rank
โ‚น195.33 B
Marketcap
โ‚น2,964
Share price
0.12%
Change (1 day)
27.17%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.52 Billion, an increase over its 2023 earnings that were of -โ‚น3.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8847.73%
2024 -โ‚น0.52 Billion-82.77%
2023 -โ‚น3.02 Billion-85.59%
2022 -โ‚น20.9 Billion60.71%
2021 -โ‚น13.01 Billion-60.08%
2020 -โ‚น32.57 Billion-331.44%
2019 โ‚น14.07 B-523.76%
2018 -โ‚น3.33 Billion-72.34%
2017 -โ‚น12.01 Billion-329.59%
2016 โ‚น5.22 B-144.3%
2015 -โ‚น11.81 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
โ‚น1.174 T-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น2.907 T-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น816.71 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น148.97 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น4.8 Billion-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น730.35 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น159.02 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น836.69 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.072 T-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA